Showing results (791-800 of 824) with videos related to
Sort By:
Pageof 83
The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.Health Technology Assessment (Winchester, England)|April 27, 2010
Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trialE Dormandy, S Bryan, M C Gulliford, et al.Nature Immunology|January 9, 2025
IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programsBrendan M Barton, Francheska Son, Akanksha Verma, et al.Science (New York, N.Y.)|September 4, 2025
Order-to-disorder transition due to entropy in layered and 2D carbidesBrian C Wyatt, Yinan Yang, Paweł P Michałowski, et al.Cell Host & Microbe|March 20, 2012
Cofactors required for TLR7- and TLR9-dependent innate immune responsesChih-Yuan Chiang, Alex Engel, Amanda M Opaluch, et al.Proceedings of the National Academy of Sciences of the United States of America|April 19, 2019
Modular, stereocontrolled Cβ-H/Cα-C activation of alkyl carboxylic acidsMing Shang, Karla S Feu, Julien C Vantourout, et al.The New Phytologist|November 14, 2022
Optimal stomatal theory predicts CO2 responses of stomatal conductance in both gymnosperm and angiosperm treesAnna Gardner, Mingkai Jiang, David S Ellsworth, et al.Journal of Medicinal Chemistry|March 4, 2008
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degenerationMoorthy S S Palanki, Hideo Akiyama, Peter Campochiaro, et al.Nature Communications|July 12, 2018
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitudeJacob S Brenner, Daniel C Pan, Jacob W Myerson, et al.Proceedings of the National Academy of Sciences of the United States of America|February 2, 2020
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrierOscar A Marcos-Contreras, Colin F Greineder, Raisa Yu Kiseleva, et al.Pageof 83